Edmund A. Gehan
#91,200
Most Influential Person Now
Edmund A. Gehan's AcademicInfluence.com Rankings
Edmund A. Gehanmathematics Degrees
Mathematics
#4493
World Rank
#6370
Historical Rank
Statistics
#230
World Rank
#285
Historical Rank
Download Badge
Mathematics
Why Is Edmund A. Gehan Influential?
(Suggest an Edit or Addition)Edmund A. Gehan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. (1965) (3335)
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. (1978) (1692)
- Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. (1966) (1401)
- The Third Intergroup Rhabdomyosarcoma Study. (1995) (901)
- The intergroup rhabdomyosarcoma study‐I. A final report (1988) (807)
- The intergroup rhabdomyosarcoma study‐II (1993) (677)
- The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. (1961) (672)
- Estimation of human body surface area from height and weight. (1970) (597)
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. (1990) (519)
- The properties of high-dimensional data spaces: implications for exploring gene and protein expression data (2008) (516)
- Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification‐an intergroup rhabdomyosarcoma study (1995) (500)
- Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. (2000) (381)
- Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. (1990) (364)
- The intergroup rhabdomyosarcoma study. A preliminary report (1977) (332)
- A generalized two-sample Wilcoxon test for doubly censored data. (1965) (298)
- The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy (1963) (290)
- Prognostic factors in metastatic breast cancer treated with combination chemotherapy. (1979) (281)
- Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. (1990) (258)
- Non-randomized controls in cancer clinical trials. (1974) (249)
- Estimating survival functions from the life table. (1969) (234)
- Pretreatment TNM staging of childhood rhabdomyosarcoma (1997) (230)
- Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. (1988) (228)
- Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. (1997) (227)
- Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. (1985) (221)
- Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. (2005) (214)
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate (1961) (206)
- Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies (1990) (203)
- Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma (1971) (194)
- Prognostic factors in multiple myeloma (1975) (189)
- Factors related to length of complete remission in adult acute leukemia (1980) (169)
- Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria (1977) (168)
- Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III (1999) (164)
- Combination chemotherapy for multiple myeloma (1972) (159)
- Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). (1987) (157)
- Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. (1991) (157)
- Multivariate analysis of prognostic factors in metastatic breast cancer. (1983) (154)
- Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. (1967) (153)
- Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. (1991) (152)
- Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. (1973) (152)
- Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. (1974) (151)
- Improved prospects for long-term survival in adults with acute myelogenous leukemia. (1982) (144)
- Necrotizing colitis in patients with cancer. (1979) (142)
- Statistical methods for the identification and use of prognostic factors (1974) (139)
- Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers (2004) (137)
- Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? (2000) (134)
- The effect of chemotherapy on acute leukemia in the human. (1961) (133)
- Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence (2005) (130)
- RANDOMIZED TRIAL OF PROTECTED ENVIRONMENT — PROPHYLACTIC ANTIBIOTICS IN 145 ADULTS WITH ACUTE LEUKEMIA (1978) (125)
- An optimal three-stage design for phase II clinical trials. (1994) (122)
- Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. (1991) (120)
- Three‐year relapse‐free survival rates in childhood rhabdomyosarcoma of the head and neck: Report from the intergroup rhabdomyosarcoma study (1982) (119)
- A four‐year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia (1981) (119)
- Combination therapy for multiple myeloma (1977) (116)
- A Monte Carlo study of the power of some two-sample tests (1975) (115)
- Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia (1971) (114)
- A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia (1982) (110)
- Prognostic factors in acute leukemia. (1976) (109)
- Prognostic factors for patients with brain tumors. (1977) (107)
- Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. (2002) (107)
- Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5‐FU vs. methyl‐CCNU plus bolus weekly 5‐FU. A southwest oncology group study (1976) (105)
- Reporting outcomes in Hodgkin's disease and lymphoma. (1987) (103)
- Intergroup Ewing's sarcoma study. Local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma (1980) (102)
- A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models. (1976) (102)
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study. (1981) (101)
- The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer Cells (2004) (93)
- Complete remissions in metastatic breast cancer treated with combination drug therapy. (1979) (93)
- Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. (1985) (90)
- Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classifications (1994) (90)
- Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. (1989) (90)
- Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix a comparison of the results in intergroup rhabdomyosarcoma studies i and ii (1990) (90)
- Unmaintained remissions in multiple myeloma. (1978) (90)
- Therapy of acute myelogenous leukemia (1978) (88)
- Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. (1992) (86)
- Paratesticular sarcoma in childhood and adolescence: A report from the intergroup rhabdomyosarcoma studies I and II, 1973–1983 (1987) (85)
- Planning and analysis of clinical studies (1971) (82)
- Progressive Loss of Syk and Abnormal Proliferation in Breast Cancer Cells (2004) (80)
- Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response. (1974) (79)
- Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the intergroup rhabdomyosarcoma study (1987) (77)
- Disease patterns and survival rate in children with metastatic soft‐tissue sarcoma: A report from the intergroup rhabdomyosarcoma study (IRS)‐I (1988) (77)
- PROLONGATION OF POSTOPERATIVE DISEASE-FREE INTERVAL AND SURVIVAL IN HUMAN COLORECTAL CANCER BY B.C.G. OR B.C.G. PLUS 5-FLUOROURACIL (1976) (75)
- Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy. (1976) (74)
- Simple Regression Methods for Survival Time Studies (1973) (73)
- Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Inter (1988) (72)
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA (1975) (71)
- Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer (1982) (71)
- Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. (1994) (70)
- Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. (1997) (70)
- The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. (1981) (68)
- Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer (1978) (68)
- Gene selection for microarray data analysis using principal component analysis (2005) (68)
- Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950s, 1960s, and 1970s (1985) (66)
- Ewing's sarcoma of the vertebral column. (1979) (65)
- Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. (1978) (64)
- Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. (1974) (64)
- L‐asparaginase therapy in children with advanced leukemia The Southwest cancer chemotherapy study group (1971) (60)
- Prognostic factors in children with rhabdomyosarcoma. (1981) (59)
- Multidrug chemotherapy in pulmonary treatment of osteosarcoma. (1976) (59)
- Evaluation of mithramycin in the treatment of anaplastic gliomas. (1976) (59)
- Comparison of survival curves, 1956 versus 1962, in children with Wilms' tumor and neuroblastoma. Report of the Subcommittee on Childhood Solid Tumors, Solid Tumor Task Force, National Cancer Institute. (1970) (58)
- Preservation of the bladder in patients with rhabdomyosarcoma. (1997) (58)
- Historical and methodological developments in clinical trials at the National Cancer Institute. (1990) (57)
- Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins. (1993) (54)
- Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study. (1995) (53)
- Extremity lesions in the intergroup rhabdomyosarcoma study (IRS‐I): A preliminary report (1982) (53)
- Pretreatment flow cytometry of DNA content in adult acute leukemia. (1980) (52)
- A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. (1997) (51)
- Marrow cytometry and prognosis in myeloma. (1983) (51)
- The evaluation of therapies: historical control studies. (1984) (49)
- Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED) (1979) (49)
- Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report. (1979) (48)
- New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy‐negative stage I and stage II patients (1977) (48)
- The intergroup Hodgkin's disease in children. A study of stages I and II (1990) (48)
- Prognostic factors in localized Hodgkin's disease treated with regional radiation. Clinical presentation and specific histology. (1971) (48)
- Prognostic factors in children with Ewing's sarcoma. (1981) (44)
- Clinical studies in malignant gliomas and their treatment with the nitrosoureas. (1976) (44)
- Block principal component analysis with application to gene microarray data classification (2002) (42)
- Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study. (1981) (41)
- Remission maintenance therapy for meningeal leukemia: intrathecal methotrexate vs. intravenous bis-nitrosourea. (1971) (40)
- Parameningeal rhabdomyosarcoma: results of an international workshop. (1996) (40)
- A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. (1987) (38)
- Cyclophosphamide Dose Escalation in Combination with Vincristine and Actinomycin‐D (VAC) in Gross Residual Sarcoma: A Pilot Study Without Hematopoietic Growth Factor Support Evaluating Toxicity and Response (1995) (38)
- Multimodal therapy in metastatic Ewing's sarcoma: an Intergroup Study. (1981) (36)
- The performance of some two-sample tests in small samples with and without censoring (1969) (36)
- Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer (2001) (35)
- Spindle and giant cell carcinoma of the thyroid: A different therapeutic approach (1974) (35)
- Sample size and power determination for clustered repeated measurements (2002) (35)
- Carcinoma of the Prostate: A Continuing Co-Operative Study* (1964) (34)
- Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study. (1981) (34)
- Developmental therapy in adult acute leukemia. (1976) (32)
- Cancer Clinical Trials: Methods and Practice (1985) (32)
- Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin. (1978) (32)
- Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. (1978) (32)
- Radiation to regional nodes for rhabdomyosarcoma of the genitourinary tract in children: Is it necessary?. A report from the intergroup rhabdomyosarcoma study #1 (IRS‐1) (1980) (32)
- Rhabdomyosarcoma of the female urogenital tract. (1981) (31)
- Definition of cure for Hodgkin's disease. (1971) (31)
- Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma (2015) (30)
- Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study. (1991) (30)
- Postsplenectomy sepsis and other complications following staging laparotomy for Hodgkin's disease in childhood. (1986) (29)
- A modification of Simon's optimal design for phase II trials when the criterion is median sample size. (1999) (28)
- COMPARATIVE TRIAL OF CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH NON-RESECTABLE CANCER OF THE LUNG. (1963) (27)
- Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer (1999) (27)
- Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. (1976) (26)
- Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy (1981) (26)
- Newer techniques and some problems in cooperative group studies. (1960) (25)
- A computer program for estimating survival functions from the life table (1970) (24)
- Statistics in Medical Research: Developments in Clinical Trials (1994) (24)
- Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report. (1982) (23)
- Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute. (1986) (23)
- Clinical trials in cancer research. (1979) (22)
- Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy-responsive stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. (1990) (22)
- SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas. (2004) (22)
- Dose—response relationship in clinical oncology (1984) (21)
- The use of the Robinson in vitro agar culture assay in adult acute leukemia. (1976) (20)
- Sarcomas of bone in childhood: pathologic aspects. (1981) (20)
- Evaluation of a new chemotherapeutic agent in patients with 'advanced refractory' acute leukemia. Studies of 6-azauracil. (1960) (19)
- Neoplasia, kinetics, nd chemotherapy. (1976) (18)
- Methods for measurement of body surface area. (1979) (18)
- Cancer clinical trials. A rational basis for use of historical controls. (1981) (16)
- Management of adult acute leukemia a southwest oncology group study (1983) (16)
- Computerized simple regression methods for survival time studies (1971) (16)
- Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study. (1986) (16)
- Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group. (1979) (15)
- Long‐term outcomes after radical prostatectomy performed in a community‐based health maintenance organization (2004) (15)
- Further clinical studies of combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-flourouracil in solid tumors (1971) (14)
- Statistics in Medical Research (2012) (14)
- Biostatistics in the new millennium: a consulting statistician's perspective (2000) (13)
- Stage I Hodgkin's disease. Comparison of surgical staging with incidence of new manifestations in lymphogram- and prelymphogram-studied patients. (1972) (13)
- Effect of formaldehyde wound wash on development of local wound recurrences. (1959) (13)
- The training of statisticians for cooperative clinical trials: a working statistician's viewpoint. (1980) (13)
- Treatment of lower torso stages I and Ii Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone (1990) (13)
- Progress of therapy in acute leukemia 1948-1981: randomized versus nonrandomized clinical trials. (1982) (12)
- Update on planning of phase II clinical trials. (1986) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- A comparative study of optimal medical care with and without azaserine in multiple myeloma (1961) (12)
- Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival. (1979) (12)
- Hepatitis B Screening Practice among Older Chinese in the Greater Washington, DC, Area (2014) (11)
- Plain radiographic predictors of survival in treated Ewing's sarcoma (2004) (11)
- Operating Characteristic Curves and Accept-Reject Rules for Two and Three Stage Screening Procedures (1964) (11)
- Disease Patterns and Survival Rate in Children With Metastatic Soft-Tissue Sarcoma: A Report From the Intergroup Rhabdomyosarcoma Study (IRS)-I (1989) (10)
- New prognostic factors affecting response and survival in adult acute leukemia (1974) (10)
- Treatment-subgroup interaction: an example from a published, phase II clinical trial. (2009) (9)
- Team approach to management of non-Hodgkin's lymphomas: past and present. (1977) (9)
- Editorial: Historical controls reincarnated: an examination of techniques for clinical therapeutic research. (1974) (9)
- Response to: "Is it ethical Not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma? (1983) (9)
- Phase II trial of bisantrene in patients with advanced sarcoma: a Southwest Oncology Group Study. (1986) (9)
- Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy. (1973) (8)
- The prediction of muscle potassium from blood electrolytes in potassium depleted rats. (1958) (8)
- Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy. (2001) (8)
- A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease. (1982) (8)
- The 6-MP versus placebo clinical trial in acute leukemia (2011) (8)
- Supplementary analysis of probabilities at the termination of a group sequential phase II trial (2005) (8)
- Early History of Pathology Studies by the Intergroup Rhabdomyosarcoma Study Group (1999) (7)
- Design of controlled clinical trials: use of historical controls. (1982) (7)
- The scientific basis of clinical trials: statistical aspects. (1997) (7)
- Use of prognostic factors in analysis of historical control studies. (1980) (7)
- Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). (1986) (7)
- Note on the "Birthday Problem" (1968) (7)
- The role of the biostatistician in cancer research. (2001) (5)
- Comparative clinical trials with historical controls: a statistician's view. (1978) (5)
- The Teacher's Corner: Note on the “Birthday Problem” (1968) (5)
- The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future. (2007) (5)
- Radiotherapy (RT) for rhabdomyosarcoma (RMS) in children: A report from the intergroup rhabdomyosarcoma study #2 (IRS-2) (Funding # CA 24507) (1984) (5)
- Sequential chemotherapy in the treatment of cancer of the head and neck (1977) (4)
- Chemoimmunotherapy of adult acute leukemia (CIAL) (1977) (4)
- Immunotherapy: its possible application in the management of large-bowel cancer. (1974) (4)
- Lenalidomide following rituximab and fludarabine in untreated CLL. (2011) (4)
- Ofatumumab and Bendamustine in Previously Treated CLL and SLL (2011) (4)
- Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients. (2002) (4)
- A controlled clinical trial to evaluate a protected environment and prophylactic antibiotic program in the treatment of adult acute leukemia. (1975) (4)
- Randomized or historical control groups in cancer clinical trials: are historical controls valid? (1986) (4)
- Evaluation of results of new treatments for osteosarcoma. (1980) (3)
- Medical registers as historical controls: analysis of an open clinical trial of inosiplex in subacute sclerosing panencephalitis. (1984) (3)
- Dose-response relationship in clinical oncology (1985) (3)
- Spindle and giant cell carcinoma of the thyroid: a different therapeutic approach. (1974) (3)
- Rhabdomyosarcoma of the Female Urogenital Tract (1982) (3)
- CONGENITAL MALFORMATIONS ASSOCIATED WITH RHABDOMYO SARCOMA: AN ASSOCIATION WITH CENTRAL NERVOUS AND GENITOURINARY SYSTEMS ANOMALIES. A REPORT FROM THE INTERGROUP RHABDOMYOSARCOMA STUDY (IRS) (1984) (3)
- Methodological issues in cancer clinical trials: the comparison of therapies. (1988) (3)
- Use of medical measurements to predict the course of disease. (1960) (3)
- Remembrances of Max Halperin. (1990) (2)
- A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients (2005) (2)
- Elementary probability for the biological sciences. (1969) (2)
- New progressive factors affecting response and survival in adult acute leukemia. (1974) (2)
- Relationship of prenatal irradiation to death from a malignant disease. (1972) (2)
- [Ethical Guidelines for Statistical Practice: Report of the Ad Hoc Committee on Professional Ethics]: Comment (1983) (2)
- Clinical Trials in the United States (1994) (2)
- A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients. (1987) (2)
- Bendamustine and Lenalidomide in Relapsed/Refractory CLL (2011) (2)
- Bendamustine and lenalidomide in relapsed/refractory lymphoid malignancies. (2011) (1)
- Local control and survival related to radiation dose and volume and to chemotherapy in Ewing's sarcoma in the pelvis (1977) (1)
- Early studies of anticancer agents in humans: the question of sample size. (1962) (1)
- Statistical Methods in Medical Research: Developments in Clinical Trials. (1996) (1)
- The role of computers at the Cancer Chemotherapy National Service Center. (1960) (1)
- Its possible application in the management of large-bowel cancer (1974) (1)
- Knowledge acquisition from historical data: application to breast cancer patients. (1980) (1)
- Early human studies with anticancer agents: the question of sample size. (1962) (1)
- Adjuvant therapy of stage II, III breast cancer. (1978) (1)
- Cell of Origin in Richter's Transformation of CLL (2012) (1)
- Radical prostatectomy--possible indications for postoperative radiotherapy. (1992) (1)
- Sampling and screening problems in a rheumatic heart disease case-finding study. (1958) (1)
- 5.6 Ofatumumab and Bendamustine in Previously Treated CLL and SLL (2011) (1)
- Gehan–Gilbert Test† (2006) (0)
- Refractory" Acute Leukemia. Studies of 6-Azauracil Evaluation of a New Chemotherapeutic Agent in Patients with "Advanced (2011) (0)
- Radiation of rhabdomyosarcoma in children combined with systemic chemotherapy: local control in patients enrolled into the intergroup study (1978) (0)
- Researchers and Statisticians Come Together (1994) (0)
- 5.5 Bendamustine and Lenalidomide in Relapsed/Refractory CLL (2011) (0)
- Leukemia: 6-Mercaptopurine and Methotrexate Studies of Sequential and Combination Antimetabolite Therapy in Acute (2013) (0)
- A two-stage estimation procedure when there may be spurious observations (1974) (0)
- Clinical Trials, Early Cancer and Heart Disease (2005) (0)
- Ethical issues in clinical trials. (1988) (0)
- A phase II design for therapies which may be ineffective (1991) (0)
- Lenalidomide following fludarabine and rituximab in previously untreated CLL (2015) (0)
- The constrution of two- and three-stage screening procedures. (1962) (0)
- The Dawning of Statistics (1994) (0)
- Reporting of clinical trials. (1990) (0)
- Parameningeal rhabdomyosarcoma: results of an international workshop on irradiation (1994) (0)
- Lenalidomide Following Rituximab and Fludarabine in Untreated CLL (2012) (0)
- The role of radiotherapy in the intergroup ewing's sarcoma study (1977) (0)
- Prognostic factors in response to anthracyclines. (1981) (0)
- 17. Clinical Trials, Early Cancer and Heart Disease (2014) (0)
- Survival curves, prognostic factors and continuous medical record analysis in acute leukemia. (1976) (0)
- Is hyperfractionated radiation plus chemotherapy feasible and tolerable in children with rhabdomyosarcoma (1994) (0)
- 924 IMPROVED SURVIVAL OF CHILDREN WITH GROUP III RHABDOMYOSARCOMA (NON-SPECIAL PELVIC SITES) (1985) (0)
- Abstract B74: Effects of a culturally targeted physician communication intervention on colorectal cancer screening among older Chinese American patients (2015) (0)
- BOOK REVIEW: The Cambridge Dictionary of Statistics in the Medical Sciences. B. S. Everitt, Cambridge University Press, 1995. No. of pages: 277. Price: $54.95 (hardback), $19.95 (paperback). ISBN 0 521 47382 9 (hardback). ISBN: 0 521 47928 2 (paperback) (1997) (0)
- Designs and Analyses of Studies of Historical Importance (1994) (0)
- ZAP-70 Expression in Chronic Lymphocytic Leukemia (CLL) Is Independent of Rai Stage: A Retrospective Review of 38 Patients (pts). (2004) (0)
- Nonrandomized Trials: Introduction (2014) (0)
- The Awakening of Statistics in the United States (1994) (0)
- Prognostic value of radiographic characteristics in Ewing's sarcoma (1978) (0)
- On the ethical aspects of the testimony of statisticians in court (2002) (0)
- Insulin dose-glucose response relationships in normal, hypophysectomized and hypophysectomized alloxan-diabetic mice. (1961) (0)
- l Clinical Original Contribution PARAMENINGEAL RHABDOMYOSARCOMA: RESULTS OF AN INTERNATIONAL WORKSHOP (1996) (0)
- Therapy of acute myelogeneous leukemia. (1978) (0)
- Statistics Becomes a Distinct Discipline (1994) (0)
- RADICAL PROSTATECTOMY - POSSIBLE INDICATIONS FOR POSTOPERATIVE RADIOTHERAPY. AUTHOR'S REPLIES (1992) (0)
- Pelvic rhabdomyosarcoma in children: is radiotherapy necessary to the regional nodes? (1979) (0)
- Combination Chemotherapy in Advanced Hodgkin's Disease (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edmund A. Gehan?
Edmund A. Gehan is affiliated with the following schools:
